MedPath
FDA Approval

Argatroban

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 16, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Argatroban(50 mg in 50 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Caplin Steriles Limited

Fresenius Kabi USA, LLC

650744670

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Argatroban

Product Details

NDC Product Code
65219-429
Application Number
ANDA214235
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
March 1, 2021
AlcoholInactive
Code: 3K9958V90MClass: IACT
Propylene GlycolInactive
Code: 6DC9Q167V3Class: IACT
Code: IY90U61Z3SClass: ACTIMQuantity: 50 mg in 50 mL
Sodium ChlorideInactive
Code: 451W47IQ8XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath